Cynthia Mohandas1, Riccardo Bonadonna2, Fariba Shojee-Moradie3, Nicola Jackson3, Linda Boselli4, K George M M Alberti1, Janet L Peacock5, A Margot Umpleby3, Stephanie A Amiel1, Louise M Goff1. 1. Division of Diabetes and Nutritional Sciences, Faculty of Life Sciences and Medicine, King's College London, London, UK. 2. Department of Medicine and Surgery, University of Parma and Azienda Ospedaliera Universitaria di Parma, Parma, Italy. 3. Faculty of Health and Medical Sciences, University of Surrey, Guildford, UK. 4. Division of Endocrinology and Metabolic Disease, University of Verona School of Medicine, Verona, Italy. 5. School of Population Health and Environmental Sciences, King's College London, London, UK.
Abstract
AIM: To test the hypothesis that men of black (West) African ethnicity (black African men [BAM]) with early type 2 diabetes (T2D) would have greater insulin secretory deficits compared with white European men (WEM), following prediabetic hypersecretion. METHODS: In 19 BAM and 15 WEM, matched for age, body mass index and duration of diabetes, we assessed and modelled insulin secretory responses to hyperglycaemia stimulated intravenously (hyperglycaemic clamp) and orally (meal tolerance test). RESULTS: With similar post-challenge glucose responses, BAM had lower second-phase C-peptide responses to intravenous glucose (BAM 70.6 vs WEM 115.1 nmol/L/min [ratio of geometric mean 0.55, 95% confidence interval {CI} 0.37, 0.83]; P = .006) and to oral glucose (BAM 65.4 vs WEM 88.5 nmol/L/min [mean difference -23.2, 95% CI -40.0, -6.3]; P = .009). Peripheral insulin response in BAM to oral glucose was preserved (BAM 47.4 vs WEM 59.4 nmol/L/min [ratio of geometric mean 0.89, 95% CI 0.59, 1.35]; P = .566), with relative reductions in insulin clearance (BAM 506.2 vs WEM 630.1 mL/m2 BSA/min [mean difference -123.9, 95% CI -270.5, 22.6]; P = .095), associated with enhanced incretin responses (gastric inhibitory polypeptide incremental area under the curve: BAM 46.8 vs WEM 33.9 μg/L/min [mean difference 12.9, 95% CI 2.1, 23.7]; P = .021). CONCLUSIONS: In early T2D, BAM had significantly lower insulin secretory responses to intravenous and oral stimulation than WEM. Lower insulin clearance, potentially driven by increased incretin responses, may act to preserve peripheral insulin concentrations. Tailoring early management strategies to reflect distinct ethnic-specific pathophysiology may improve outcomes in this high-risk population.
AIM: To test the hypothesis that men of black (West) African ethnicity (black African men [BAM]) with early type 2 diabetes (T2D) would have greater insulin secretory deficits compared with white European men (WEM), following prediabetic hypersecretion. METHODS: In 19 BAM and 15 WEM, matched for age, body mass index and duration of diabetes, we assessed and modelled insulin secretory responses to hyperglycaemia stimulated intravenously (hyperglycaemic clamp) and orally (meal tolerance test). RESULTS: With similar post-challenge glucose responses, BAM had lower second-phase C-peptide responses to intravenous glucose (BAM 70.6 vs WEM 115.1 nmol/L/min [ratio of geometric mean 0.55, 95% confidence interval {CI} 0.37, 0.83]; P = .006) and to oral glucose (BAM 65.4 vs WEM 88.5 nmol/L/min [mean difference -23.2, 95% CI -40.0, -6.3]; P = .009). Peripheral insulin response in BAM to oral glucose was preserved (BAM 47.4 vs WEM 59.4 nmol/L/min [ratio of geometric mean 0.89, 95% CI 0.59, 1.35]; P = .566), with relative reductions in insulin clearance (BAM 506.2 vs WEM 630.1 mL/m2 BSA/min [mean difference -123.9, 95% CI -270.5, 22.6]; P = .095), associated with enhanced incretin responses (gastric inhibitory polypeptide incremental area under the curve: BAM 46.8 vs WEM 33.9 μg/L/min [mean difference 12.9, 95% CI 2.1, 23.7]; P = .021). CONCLUSIONS: In early T2D, BAM had significantly lower insulin secretory responses to intravenous and oral stimulation than WEM. Lower insulin clearance, potentially driven by increased incretin responses, may act to preserve peripheral insulin concentrations. Tailoring early management strategies to reflect distinct ethnic-specific pathophysiology may improve outcomes in this high-risk population.
Authors: Amy E Mendham; Lisa K Micklesfield; Fredrik Karpe; Andre Pascal Kengne; Tinashe Chikowore; Clement N Kufe; Maphoko Masemola; Nigel J Crowther; Shane A Norris; Tommy Olsson; Sölve Elmståhl; Tove Fall; Lars Lind; Julia H Goedecke Journal: Diabetologia Date: 2022-09-17 Impact factor: 10.460
Authors: Oluwatoyosi Bello; Cynthia Mohandas; Fariba Shojee-Moradie; Nicola Jackson; Olah Hakim; K George M M Alberti; Janet L Peacock; A Margot Umpleby; Stephanie A Amiel; Louise M Goff Journal: Diabetologia Date: 2019-02-06 Impact factor: 10.122
Authors: Meera Ladwa; Oluwatoyosi Bello; Olah Hakim; Fariba Shojaee-Moradie; Maria Linda Boselli; Geoff Charles-Edwards; Janet Peacock; A Margot Umpleby; Stephanie A Amiel; Riccardo C Bonadonna; Louise M Goff Journal: BMJ Open Diabetes Res Care Date: 2021-03
Authors: Meera Ladwa; Oluwatoyosi Bello; Olah Hakim; Maria Linda Boselli; Fariba Shojaee-Moradie; A Margot Umpleby; Janet Peacock; Stephanie A Amiel; Riccardo C Bonadonna; Louise M Goff Journal: Acta Diabetol Date: 2021-10-18 Impact factor: 4.280
Authors: Juraj Koska; Daniel S Nuyujukian; Gideon D Bahn; Jin J Zhou; Peter D Reaven Journal: Cardiovasc Diabetol Date: 2021-12-08 Impact factor: 9.951
Authors: Om Prakash Dwivedi; Mikko Lehtovirta; Benoit Hastoy; Vikash Chandra; Nicole A J Krentz; Sandra Kleiner; Deepak Jain; Ann-Marie Richard; Fernando Abaitua; Nicola L Beer; Antje Grotz; Rashmi B Prasad; Ola Hansson; Emma Ahlqvist; Ulrika Krus; Isabella Artner; Anu Suoranta; Daniel Gomez; Aris Baras; Benoite Champon; Anthony J Payne; Daniela Moralli; Soren K Thomsen; Philipp Kramer; Ioannis Spiliotis; Reshma Ramracheya; Pauline Chabosseau; Andria Theodoulou; Rebecca Cheung; Martijn van de Bunt; Jason Flannick; Maddalena Trombetta; Enzo Bonora; Claes B Wolheim; Leena Sarelin; Riccardo C Bonadonna; Patrik Rorsman; Benjamin Davies; Julia Brosnan; Mark I McCarthy; Timo Otonkoski; Jens O Lagerstedt; Guy A Rutter; Jesper Gromada; Anna L Gloyn; Tiinamaija Tuomi; Leif Groop Journal: Nat Genet Date: 2019-11-01 Impact factor: 38.330